CRO ClinicalRM and the Ohio Clinical Trials Collaborative (OCTC) have announced a co-marketing partnership offering joint services for clinical trials of new biologics, drugs and medical devices. The relationship will serve the organizations’ mutual customers with a full spectrum of development services including access to a network of veteran investigators, patient population identification, clinical operations and guidance on medical/regulatory affairs.
“Expedited access to Ohio’s premier medical institutions will shorten the time to start a new multi-site clinical trial, as well as assure timely patient enrollment for our clients,” said Alan Braverman, Pharm.D., vice president of clinical operations of ClinicalRM, a 20-year-old, full-service CRO headquartered in Ohio. The firm has over 350 employees.
The OCTC offers centralized access to Ohio’s premier medical centers for trial development. It is a statewide initiative that streamlines contracting, budgeting, approval of human subject use and patient recruitment/enrollment processes to move medical discoveries to market faster. ClinicalRM supports these clinical trials with an array of clinical operations, quality management and regulatory affairs services, along with a regional and globally experienced scientific advisory board.
“Integrating ClinicalRM’s services into the OCTC’s clinical trials network will provide a powerful engine for new pharmaceutical, biologic and medical device development in Ohio,” said John Peterson, Ph.D., global business development director of the OCTC.